SS&C Technologies Holdings earnings release, October 22, 2026

SS&C Technologies Holdings Inc (SSNC) · Form 8-K, Item 2.02 · Filed · SEC filing

SS&C Technologies Releases Q3 2026 Financial Results

Q3 2026 GAAP revenue $1,690.0 million, up 7.8%, Fully Diluted GAAP Earnings Per Share $0.83

Adjusted revenue $1,691.1 million, up 7.8%, Adjusted Diluted Earnings Per Share $1.78, up 14.8%

WINDSOR, CT, October 22, 2026 (BUSINESS WIRE)

--

SS&C Technologies Holdings, Inc. (NASDAQ: SSNC), a global provider of investment, financial and healthcare technology and technology-enabled services, today announced its financial results for the third quarter ended September 30, 2026.

Financial statements

Income Statement

Three Months Ended September 30, (in millions, except per share data)

Three Months Ended September 30, – 2026Three Months Ended September 30, – 2025ChangeNine Months Ended September 30, – 2026Nine Months Ended September 30, – 2025Change
GAAP ResultsRevenue1,6901,5687.8%5,032.84,618.79.0%
GAAP ResultsOperating income409.3365.711.9%1,224.61,068.114.7%
GAAP ResultsOperating income margin24.2%23.3%90 bps24.3%23.1%120 bps
GAAP ResultsNet income198.9210-5.3%659.8603.89.3%
GAAP ResultsDiluted earnings per share0.830.832.712.3913.4%
Adjusted Non-GAAP Results (defined in Notes 1 - 4 below)Adjusted revenue1,691.11,5697.8%5,036.24,621.69.0%
Adjusted Non-GAAP Results (defined in Notes 1 - 4 below)Adjusted operating income657.6602.59.1%1,9451,761.310.4%
Adjusted Non-GAAP Results (defined in Notes 1 - 4 below)Adjusted operating income margin38.9%38.4%50 bps38.6%38.1%50 bps
Adjusted Non-GAAP Results (defined in Notes 1 - 4 below)Adjusted consolidated EBITDA674.86199.0%1,996.51,811.310.2%
Adjusted Non-GAAP Results (defined in Notes 1 - 4 below)Adjusted consolidated EBITDA margin39.9%39.5%40 bps39.6%39.2%40 bps
Adjusted Non-GAAP Results (defined in Notes 1 - 4 below)Adjusted diluted earnings per share(1)1.781.5514.8%5.234.5215.7%

Income Statement

Guidance

Q4 2026FY 2026
Adjusted Revenue ($M)$1,700 – $1,740$6,736 – $6,776
Adjusted Net Income ($M)$454 – $470$1,726 – $1,742
Interest Expense1 ($M)$103 – $105$417 – $419
Adjusted Diluted Earnings per Share$1.88 – $1.94$7.11 – $7.17
Cash from Operating Activities ($M)$1,717 – $1,817
Capital Expenditures (% of revenue)4.4% – 4.8%
Diluted Shares (M)240.0 – 243.0242.7 – 242.9
Effective Income Tax Rate (%)21.5% – 23.5%21.5% – 23.5%

Income Statement

Three Months Ended September 30, — (unaudited) (in millions)

Three Months Ended September 30, – 2026Three Months Ended September 30, – 2025Nine Months Ended September 30, – 2026Nine Months Ended September 30, – 2025
Revenues:Technology-enabled services1,448.61,309.44,264.13,847
Revenues:License, maintenance and related241.4258.6768.7771.7
Revenues:Total revenues1,6901,5685,032.84,618.7
Cost of revenues:Technology-enabled services771.9714.22,2842,075.4
Cost of revenues:License, maintenance and related104.3106314.9311.5
Cost of revenues:Total cost of revenues876.2820.22,598.92,386.9
Cost of revenues:Gross profit813.8747.82,433.92,231.8
Operating expenses:Selling and marketing154.7144.7466.9449.4
Operating expenses:Research and development131.5118.6398.4375.8
Operating expenses:General and administrative118.3118.8344338.5
Operating expenses:Total operating expenses404.5382.11,209.31,163.7
Operating expenses:Operating income409.3365.71,224.61,068.1
Operating expenses:Interest expense, net-107.2-104.2-319.6-314.9
Operating expenses:Other income, net2.95.310.811.4
Operating expenses:Equity in earnings of unconsolidated affiliates, net-47.7-11.6-40.8-7.7
Operating expenses:Loss on extinguishment of debt-0.6-1.3-1-2.2
Operating expenses:Income before income taxes256.7253.9874754.7
Operating expenses:Provision for income taxes58.643.5214.3150
Operating expenses:Net income198.1210.4659.7604.7
Operating expenses:Net loss (income) attributable to noncontrolling interest0.8-0.40.1-0.9
Operating expenses:Net income attributable to SS&C common stockholders198.9210659.8603.8
Operating expenses:Basic earnings per share attributable to SS&C common stockholders0.850.862.772.47
Operating expenses:Diluted earnings per share attributable to SS&C common stockholders0.830.832.712.39
Operating expenses:Basic weighted-average number of common shares outstanding234.6243.8238244.8
Operating expenses:Diluted weighted-average number of common and common equivalent shares outstanding240.6252.6243.3253.1
Operating expenses:Net income198.1210.4659.7604.7
Other comprehensive (loss) income, net of tax:Foreign currency exchange translation adjustment-6.4-66.4-81.1233.9
Other comprehensive (loss) income, net of tax:Change in defined benefit pension obligation0.20.4
Other comprehensive (loss) income, net of tax:Total other comprehensive (loss) income, net of tax-6.2-66.4-80.7233.9
Other comprehensive (loss) income, net of tax:Comprehensive income191.9144579838.6
Other comprehensive (loss) income, net of tax:Comprehensive loss (income) attributable to noncontrolling interest0.8-0.40.1-0.9
Other comprehensive (loss) income, net of tax:Comprehensive income attributable to SS&C common stockholders192.7143.6579.1837.7

Income Statement

Three Months Ended September 30, (in millions)

Three Months Ended September 30, – 2026Three Months Ended September 30, – 2025Nine Months Ended September 30, – 2026Nine Months Ended September 30, – 2025
Technology-enabled services1,448.61,309.44,264.13,847
License, maintenance and related241.4258.6768.7771.7
Total revenues1,6901,5685,032.84,618.7
Technology-enabled services1,449.81,310.44,267.63,849.9
License, maintenance and related241.3258.6768.6771.7
Total adjusted revenues1,691.11,5695,036.24,621.6

Income Statement

Three Months Ended September 30, (in millions)

Three Months Ended September 30, – 2026Three Months Ended September 30, – 2025Nine Months Ended September 30, – 2026Nine Months Ended September 30, – 2025Twelve Months Ended September 30, – 2026
Net income198.1210.4659.7604.7853.7
Interest expense, net107.2104.2319.6314.9430.9
Provision for income taxes58.643.5214.3150240.4
Depreciation and amortization182.8175.4544.7521.1727.3
EBITDA546.7533.51,738.31,590.72,252.3
Stock-based compensation62.160185.8172.9270.5
Acquired EBITDA and cost savings (1)2.8
Equity in earnings of unconsolidated affiliates, net47.711.640.87.742.5
Investment losses (gains) (2)0.6-3.3-10.9-13.5-11.4
Facilities and workforce restructuring13.81232.436.241.2
Acquisition related-2.83.8-1.36.83.5
Other (3)8.61.916.112.954.4
Consolidated EBITDA676.7619.52,001.21,813.72,655.8
Acquired EBITDA and cost savings (1)-2.8
Adjusted Consolidated EBITDA676.7619.52,001.21,813.72,653
Adjusted Consolidated EBITDA attributable to noncontrolling interest (4)-1.9-0.5-4.7-2.4-5.5
Adjusted Consolidated EBITDA attributable to SS&C common stockholders674.86191,996.51,811.32,647.5

Income Statement

Three Months Ended September 30, (in millions, except per share data)

Three Months Ended September 30, – 2026Three Months Ended September 30, – 2025Nine Months Ended September 30, – 2026Nine Months Ended September 30, – 2025
GAAP – Net income198.1210.4659.7604.7
Amortization of intangible assets165.1157.8491.3467.8
Stock-based compensation62.160185.8172.9
Equity in earnings of unconsolidated affiliates, net47.711.640.87.7
Investment losses (gains) (1)2.7-1.11.42.4
Facilities and workforce restructuring13.81232.436.2
Acquisition related-2.83.8-1.36.8
Other (2)114.423.621.1
Income tax effect (3)-66.6-67-156.5-173.3
Adjusted net income431.1391.91,277.21,146.3
Adjusted net income attributable to noncontrolling interest (4)-2.1-0.5-4.9-3.2
Adjusted net income attributable to SS&C common stockholders429391.41,272.31,143.1
Adjusted diluted earnings per share attributable to SS&C common stockholders1.781.555.234.52
GAAP diluted earnings per share attributable to SS&C common stockholders0.830.832.712.39
Diluted weighted-average shares outstanding240.6252.6243.3253.1

Balance Sheet

September 30, — (unaudited) (in millions)

September 30, – 2026December 31, – 2025
Current assets:Cash and cash equivalents525.4462.1
Current assets:Funds receivable and funds held on behalf of clients3,846.53,799.5
Current assets:Accounts receivable, net1,033.7978.7
Current assets:Contract asset57.449.2
Current assets:Prepaid expenses and other current assets183.4193.7
Current assets:Restricted cash2.54.5
Current assets:Total current assets5,648.95,487.7
Current assets:Property, plant and equipment, net280.3289.5
Current assets:Operating lease right-of-use assets217.9233.3
Current assets:Investments171.3174.4
Current assets:Unconsolidated affiliates247.3307.7
Current assets:Contract asset140.2133.1
Current assets:Goodwill9,928.19,991.3
Current assets:Intangible and other assets, net3,781.24,094.7
Current assets:Total assets20,415.220,711.7
Current liabilities:Current portion of long-term debt (1)2,26025
Current liabilities:Client funds obligations3,846.53,799.5
Current liabilities:Accounts payable71.787.2
Current liabilities:Income taxes payable23.3
Current liabilities:Accrued employee compensation and benefits288.1348.9
Current liabilities:Interest payable16.731.6
Current liabilities:Other accrued expenses278.2303.4
Current liabilities:Deferred revenue444.7492.4
Current liabilities:Total current liabilities7,205.95,111.3
Current liabilities:Long-term debt, net of current portion5,189.57,408.4
Current liabilities:Operating lease liabilities205.4213.2
Current liabilities:Other long-term liabilities198.4190.2
Current liabilities:Deferred income taxes848.3846.8
Current liabilities:Total liabilities13,647.513,769.9
Current liabilities:SS&C stockholders' equity6,698.76,887.6
Current liabilities:Noncontrolling interest6954.2
Current liabilities:Total equity6,767.76,941.8
Current liabilities:Total liabilities and equity20,415.220,711.7

Cash Flow

Nine Months Ended September 30, — (unaudited) (in millions)

Nine Months Ended September 30, – 2026Nine Months Ended September 30, – 2025
Cash flow from operating activities:Net income659.7604.7
Adjustments to reconcile net income to net cash provided by operating activities:Depreciation and amortization544.7521.1
Full release

(1) Reflects non-GAAP tax rates of 22.5% for the three and nine months ended September 30, 2026 and 22.0% for the three and nine months ended September 30, 2025. See Note 4 for more information.

Third Quarter 2026 Highlights:

• Q3 2026 GAAP Revenue growth and Adjusted Revenue growth were 7.8 percent.

• Q3 2026 Adjusted Organic Revenue Growth was 5.2 percent.

• Net cash generated from operating activities of $1,216.3 million for the nine months ended September 30, 2026, up 10.4 percent compared to the same period in 2025.

• Returned $225.3 million to shareholders in Q3 2026, which included 1.9 million shares repurchased for $154.8 million and $70.5 million in common stock dividends.

• Paid down $130.0 million in debt, bringing our net leverage ratio to 2.63x

• Record adjusted consolidated EBITDA of $674.8 million for Q3 2026, up 9.0 percent. Adjusted consolidated EBITDA margin for Q3 2026 was 39.9 percent.

• GAAP operating income margin for Q3 2026 was 24.2 percent and GAAP net income of $198.9 million for Q3 2026.

• Adjusted diluted earnings per share was $1.78, up 14.8 percent.

• In August, SS&C increased our common stock dividend to $1.20 annually, an 11.1 percent increase.

"SS&C delivered another quarter of strong results, with Q3 organic revenue growth of 5.2%, record adjusted consolidated EBITDA of $674.8 million, and margins of 39.9%, keeping us on track to achieve our full-year goals," said Bill Stone, Chairman and Chief Executive Officer. "In September, we hosted over 1,000 financial services and healthcare leaders at our annual SS&C Deliver conference, and it was clear that holistic transformation of our clients' operating models is a top priority. As we harness emerging technologies like agentic AI and tokenization, SS&C is evolving in step with our clients—partnering with them, supporting them, and shaping the future together."¹

Operating Cash Flow

SS&C generated net cash from operating activities of $1,216.3 million for the nine months ended September 30, 2026, compared to $1,101.3 million for the same period in 2025, a 10.4% increase. SS&C ended the third quarter with $525.4 million in cash and cash equivalents and $7,483.5 million in gross debt. SS&C’s consolidated net leverage ratio as defined in our credit agreement stood at 2.63 times consolidated EBITDA as of September 30, 2026. SS&C’s net secured leverage ratio stood at 1.59 times consolidated EBITDA as of September 30, 2026.

Guidance¹

Interest expense is net of deferred financing cost amortization and original issue discount

SS&C does not provide reconciliations of guidance for Adjusted Revenues and Adjusted Net Income to comparable GAAP measures, in reliance on the unreasonable efforts exception provided under Item 10(e)(1)(i)(B) of Regulation S-K. SS&C is unable, without unreasonable efforts, to forecast certain items required to develop meaningful comparable GAAP financial measures. These items include acquisition transactions and integration, foreign exchange rate changes, as well as other non-cash and other adjustments as defined under the Company’s Credit agreement, that are difficult to predict in advance in order to include in a GAAP estimate. The unavailable information could have a significant impact on Q4 2026 and FY 2026 GAAP financial results.

Non-GAAP Financial Measures

Adjusted revenue, adjusted operating income, adjusted consolidated EBITDA, adjusted net income and adjusted diluted earnings per share are non-GAAP measures. See the accompanying notes for the reconciliations and definitions for each of these non-GAAP measures and the reasons our management believes these measures provide useful information to investors regarding our financial condition and results of operations. All references above to net income, diluted earnings per share, adjusted operating income, adjusted consolidated EBITDA, and adjusted diluted earnings per share are attributable to SS&C.²

Earnings Call and Press Release

SS&C’s third quarter 2026 earnings call will take place at 5:00 p.m. eastern time today, October 22, 2026. The call will discuss third quarter 2026 results. Interested parties may visit investor.ssctech.com to access the live webcast and view accompanying slides. The call will be available for replay via the webcast on SS&C’s website; access: https://investor.ssctech.com/financials/quarterly-results/default.aspx... (truncated)h not all forward-looking statements are accompanied by such words. Such statements reflect management’s best judgment based on factors currently known but are subject to risks and uncertainties, which could cause actual results to differ materially from those anticipated. Such risks and uncertainties include, but are not limited to, the state of the economy and the financial services industry and other industries in which the Company’s clients operate, the Company’s ability to realize anticipated benefits from its acquisitions, the effect of customer consolidation on demand for the Company’s products and services, the variability of revenue as a result of activity in the securities markets, the focus of the Company’s business on the asset management industry, the ability to retain and attract clients, the intensity of competition with respect to the Company’s products and services, risks from cyber-attacks, breaches of digital security, IT system failures and network disruptions, risks associated with third party providers, fluctuations in the Company’s operating results, terrorist activities and other catastrophic events, risks associated with the Company’s foreign operations, privacy concerns relating to the collection and storage of personal information, evolving regulations and increased scrutiny from regulators, the Company’s ability to protect intellectual property assets and litigation regarding intellectual property rights, delays in product development, investment decisions concerning cash balances, tax risks, risks associated with the Company’s joint ventures, changes in accounting standards, evolving regulation and scrutiny from regulators, the Company’s exposure to litigation and other claims, risks related to the Company’s substantial indebtedness, and the market price of the Company’s stock prevailing from time to time, and the risks discussed in the “Risk Factors” section of the Company’s most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q, which are on file with the Securities and Exchange Commission and can also be accessed on our website. Such “Risk Factors”, among others, could cause actual results to differ materially from those indicated by forward-looking statements made herein and presented elsewhere by management from time to time. Undue reliance should not be placed on any such forward-looking statements. Forward-looking statements speak only as of the date on which they are made and, except to the extent required by applicable securities laws, we undertake no obligation to update or revise any forward-looking statements.³

About SS&C Technologies

SS&C is a leading provider of mission-critical, AI-powered technology and services empowering financial services and healthcare organizations to work smarter, faster, and securely. Founded in 1986, SS&C is headquartered in Windsor, Connecticut, and has offices worldwide. More than 23,000 financial services and healthcare organizations, from the world's largest companies to small and mid-market firms, rely on SS&C for expertise, scale and technology.

Follow SS&C on Twitter, LinkedIn and Facebook.

For more information

Brian Schell

Chief Financial Officer

Tel: +1-816-642-0915

E-mail:

InvestorRelations@sscinc.com

Justine Stone

Head of Investor Relations

Tel: +1-212-367-4705

E-mail:

InvestorRelations@sscinc.com⁴

SS&C Technologies Holdings, Inc. and Subsidiaries

Condensed Consolidated Statements of Comprehensive Income

(in millions, except per share data)

(unaudited)⁵

SS&C Technologies Holdings, Inc. and Subsidiaries

Condensed Consolidated Balance Sheets

(in millions)

(unaudited)

(1) $2.0 billion of Senior Notes has been classified as current given the stated maturity of September 30, 2027. We are actively addressing this maturity and believe refinancing the Senior Notes is probable of occurring during the 4 th quarter of 2026.⁶

SS&C Technologies Holdings, Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows

(in millions)

(unaudited)⁷

SS&C Technologies Holdings, Inc. and Subsidiaries

Disclosures Relating to Non-GAAP Financial Measures

Note 1. Reconciliation of Revenues to Adjusted Revenues

Adjusted revenues represents revenues adjusted to include a) amounts that would have been recognized if deferred revenue were not adjusted to fair value at the date of acquisition and b) amounts that would have been recognized if not for adjustments to deferred revenue and retained earnings related to the adoption of ASC 606. Adjusted revenues is presented because we use this measure to evaluate performance of our business against prior periods and believe it is a useful indicator of the underlying performance of our business. Adjusted revenues is not a recognized term under generally accepted accounting principles (“GAAP”). Adjusted revenues does not represent revenues, as that term is defined under GAAP, and should not be considered as an alternative to revenues as an indicator of our operating performance. Adjusted revenues as presented herein is not necessarily comparable to similarly titled measures presented by other companies. Below is a reconciliation of adjusted revenues to revenues, the GAAP measure we believe to be most directly comparable to adjusted revenues.

The following is a breakdown of technology-enabled services and license, maintenance and related revenues and adjusted technology-enabled services and license, maintenance and related revenues.⁸

Note 2. Reconciliation of Operating Income to Adjusted Operating Income... (truncated)ther expenses. Adjusted operating income is presented because we use this measure to evaluate performance of our business and believe it is a useful indicator of our underlying performance. Adjusted operating income is not a recognized term under GAAP. Adjusted operating income does not represent operating income, as that term is defined under GAAP, and should not be considered as an alternative to operating income as an indicator of our operating performance. Adjusted operating income as presented herein is not necessarily comparable to similarly titled measures by other companies. The following is a reconciliation between adjusted operating income and operating income, the GAAP measure we believe to be most directly comparable to adjusted operating income.

(1)

Other includes additional expenses and income that are permitted to be excluded per the terms of our Credit Agreement from Consolidated EBITDA, a financial measure used in calculating our covenant compliance.

(2)

Adjusted operating income attributable to noncontrolling interest represents the proportionate share of adjusted operating income of DomaniRx, LLC (a consolidated joint venture) retained by our joint venture partners.⁹

Note 3. Reconciliation of Net Income to EBITDA, Consolidated EBITDA and Adjusted Consolidated EBITDA

EBITDA represents net income before interest expense, income taxes, depreciation and amortization. Consolidated EBITDA, defined under our Credit Agreement entered into in April 2018, as amended, is used in calculating covenant compliance, and is EBITDA adjusted for certain items. Consolidated EBITDA is calculated by subtracting from or adding to EBITDA items of income or expense described below. Adjusted Consolidated EBITDA is calculated by subtracting acquired EBITDA (as defined below) from Consolidated EBITDA. EBITDA, Consolidated EBITDA and Adjusted Consolidated EBITDA are presented because we use these measures to evaluate performance of our business and believe them to be useful indicators of an entity’s debt capacity and its ability to service debt. EBITDA, Consolidated EBITDA and Adjusted Consolidated EBITDA are not recognized terms under GAAP and should not be considered in isolation or as alternatives to operating income, net income or cash flows from operating activities as indicators of our operating performance. These measures are not necessarily comparable to similarly titled measures by other companies. The following is a reconciliation of EBITDA, Consolidated EBITDA and Adjusted Consolidated EBITDA to net income.

(1)

Acquired EBITDA reflects the EBITDA impact of significant businesses that were acquired during the last twelve months as if the acquisition occurred at the beginning of the trailing twelve-month period, as well as cost savings enacted in connection with acquisitions.

(2)

Investment gains includes unrealized fair value adjustments of investments and dividend income received on investments.

(3)

Other includes additional expenses and income that are permitted to be excluded per the terms of our Credit Agreement from Consolidated EBITDA, a financial measure used in calculating our covenant compliance, and includes a loss on the sale of fixed assets of $33.3 million during the twelve months ended September 30, 2026.

(4)

Adjusted Consolidated EBITDA attributable to noncontrolling interest represents the proportionate share of adjusted Consolidated EBITDA of DomaniRx, LLC (a consolidated joint venture) retained by our joint venture partners.¹⁰

Note 4. Reconciliation of Net Income to Adjusted Net Income and Diluted Earnings Per Share Attributable to SS&C to Adjusted Diluted Earnings Per Share Attributable to SS&C

Adjusted net income and adjusted diluted earnings per share attributable to SS&C represent net income and earnings per share attributable to SS&C before amortization of intangible assets and deferred financing costs, stock-based compensation, purchase accounting adjustments and other items. We consider adjusted net income and adjusted diluted earnings per share attributable to SS&C to be important to management and investors because they represent our operational performance exclusive of the effects of amortization of intangible assets and deferred financing costs, stock-based compensation, purchase accounting adjustments, loss on extinguishment of debt and other items, that are not operational in nature or comparable to those of our competitors. Adjusted net income and adjusted diluted earnings per share are not recognized terms under GAAP. Adjusted net income and adjusted diluted earnings per share do not represent net income or diluted earnings per share, as those terms are defined under GAAP, and should not be considered as alternatives to net income or diluted earnings per share as indicators of our operating performance. Adjusted net income and adjusted diluted earnings per share attributable to SS&C as presented herein are not necessarily comparable to similarly titled measures presented by other companies. Below is a reconciliation of adjusted net income and adjusted diluted earnings per share attributable to SS&C to net income and diluted earnings per share attributable to SS&C, the GAAP measures we believe to be most directly comparable to adjusted net income and adjusted diluted earnings per share.

(1)

Investment (gains) losses includes unrealized fair value adjustments of investments.

(2)

Other includes additional expenses and income that are permitted to be excluded per the terms of our Credit Agreement from Consolidated EBITDA, a financial measure used in calculating our covenant compliance.

(3)... (truncated)urpose of computing adjusted net income for the three and nine months ended September 30, 2025.

(4)

Adjusted net income attributable to noncontrolling interest represents the proportionate share of adjusted net income of DomaniRx, LLC (a consolidated joint venture) retained by our joint venture partners.¹¹

Earlier releases

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.